El tango se convierte en Patrimonio Cultural Inmaterial de la Humanidad
September 30, 2009 | In: General
PARÍS (AFP) – - El tango, música y baile por excelencia del Río de la Plata, se convirtió este miércoles en Patrimonio Cultural Inmaterial de la Humanidad, por decisión de un comité intergubernamental de la UNESCO reunido en Abu Dhabi, que aceptó una candidatura impulsada conjuntamente por Argentina y Uruguay.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.
KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.
KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro.
MADRID (AFP) – - El Sevilla FC arrancará el miércoles su andadura en la Liga de Campeones ante el campeón de la Liga rumana, el Unirea Urziceni, un debutante que llegará al estadio Sánchez Pizjuán muy motivado y dispuesto a no dejarse “impresionar por sus adversarios”.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.
The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.
The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at.
BRUSELAS (AFP) – El próximo comisario europeo de Competencia, Joaquín Almunia, dejó entrever este martes que seguirá la línea severa de su predecesora en el cargo, Neelie Kroes, cuando se trate de castigar a las empresas por prácticas contrarias a las leyes de competencia.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.
Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements.
Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext.
RAMALA, Cisjordania (AFP) – - El Cuarteto para Oriente Medio, compuesto por Estados Unidos, la Unión Europea, Rusia y Naciones Unidas, se reunirá dentro de dos semanas en Nueva York, anunció el miércoles en Ramalá (Cirsjordania), el jefe de los negociadores palestinos, Saeb Erakat.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.
KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.
The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.
He had expected the company to report abroadly unchanged like-for-like sales decline. Tracy Porter, however was seen as a player that would have to mature a little before he would be asked to contribute full time.So far this preseason Jason David has still shown he cannot play man to man, and is a liability on the field. All you are looking for is to get an easy 1-2-3 inning under your belt so you can go back into your dugout and win it in the bottom of the ninth. Cobb arrived in France safely and prepared to face the enemy. The War Department broke the news that Major League Baseball could resume in 1919 to Ban Johnson on December 4th. InterCall UnifiedMeeting offers customers an easy and simple way to share documents andsoftware with people around the world without the need for complicatedtechnology. They include Prospera brachytherapy seeds andSurTRAK needles and strands used primarily in the treatment of prostate cancer.In addition, the Company has continued to gain clinical experience with itsClearPath multi-channel catheter breast brachytherapy devices.
Airgas National Welders was nominated for theaward by the Defense Energy Support Center (DESC), and will accept the awardfrom DLA Director Vice Admiral Alan S. Law (March 11-12, 2009 )The U.S. La Société compteplus de 10 000 employés, et ses revenus annuels se chiffrent à plus de 70milliards $; son siège social est situé à Valley Forge, en Pennsylvanie.AmerisourceBergen occupe le 28e rang au classement Fortune 500. With an All-Star goalie in net and two of the best players in the league on offense, that is inexcusable. So why will Mangini be first to go down? It’s usually rare to see a new coach fired in his first year with a team, but we did just witness multiple offensive coordinators being fired a week before the season started.
Global Markets | China | Russia | France | Japan The Global Total Output Index, produced by JP Morgan withresearch and supply management organisations, rose to 40.2 inJanuary from 37.3 in December, but was still well below the 50.0mark that divides growth from contraction. Cash GeneratorsThe success of Kodak`s core investments stems in part from the company`s abilityto maximize its cash-generating businesses. Snap out of it.An aside: Did you notice in Saturday’s game that three ex-Phillies came to the plate in consecutive at-bats? Jason Michaels, Coste, and Michael Bourn.. However, this season his OBP has been on the upswing as it currently stands at .393, which is 11th in the American League.-Clubhouse presence?Everyone knows just how valuable Abreu has been to the Angels this season based on his numbers. On Wednesday, rating firm Fitchdowngraded Russia’s sovereign ratings while Kazakhstan centralbank’s decided to devalue its currency.
MEERBEKE, Bélgica (AFP) – El suizo Fabian Cancellara (Saxo Bank) ganó este domingo en solitario la 94ª edición del Tour de Flandes, la gran clásica ciclista belga, que no tenía en su palmarés y que cubrió un recorrido de 261,5 kilómetros entre las ciudades de Brujas y Meerbeke.
The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research.
“The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades.
Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys.
What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers.
LONDRES (AFP) – Los vestidos estructurados de lana, los brillos y las joyas volvieron a la Semana de la Moda de Londres este domingo de la mano de Matthew Williamson, en un día dedicado a los grandes talentos británicos como Vivienne Westwood.
The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits.
DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies.
Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009.
DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation. Sales also tend to fluctuateyear on year, as specific exclusivities are gained and expire. Fluoxetine andciprofloxacin are notable examples in recent years. In June 2006, Barr’s offer to acquire Pliva was accepted by the board of theCroatian company. Barr faced strong competition for Pliva from Actavis, althoughthe Icelandic company dropped out of contention after a three month bidding war.The acquisition was completed in October 2006, making Barr one of the world’slargest generic manufacturers, with an enhanced presence in Europe The dealrequired a restructuring process for Barr.
BUENOS AIRES (AFP) – La justicia argentina investiga una red de espionaje telefónico que salpica al derechista alcalde de la capital, Mauricio Macri, y busca determinar si la presidenta Cristina Kirchner y su esposo, el ex mandatario Néstor Kirchner, fueron víctimas de dicha red.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.
The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx.
The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.
EL CAIRO (AFP) – - El tráfico gigantesco existente en las ciudades de Egipto, particularmente en El Cairo, y los muchos ojeadores de clubes europeos que se citan en los siete estadios del Mundial Sub-20 son dos de los invitados que se han hecho importantes en el torneo juvenil.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.
This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.
The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.
BELFAST (AFP) – Los líderes de los partidos protestante y católico en Irlanda del Norte llevaron a cabo este lunes largas discusiones con sus bases y reafirmaron su esperanza de llegar a un acuerdo para evitar una desintegración del gobierno regional biconfesional.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.
Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.
WASHINGTON (AFP) – Excluido del congelamiento de gastos decidido por el gobierno estadounidense, el Pentágono obtuvo un incremento de 700.000 millones de dólares en su presupuesto para el año 2011, con énfasis en el combate a los extremistas más que en los conflictos convencionales.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement.
Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization.
MADRID (AFP) – Patrick Mtiliga, el defensa danés del Málaga a quien el delantero portugués Cristiano Ronaldo rompió la nariz de un codazo, el domingo en el partido liguero contra el Real Madrid, deberá guardar una semana de reposo y luego llevará una máscara protectora.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.
Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.
This strategy generates significant amounts of depreciation and deferredtaxes.The Company believes EBDDT is useful, along with net income, tounderstanding the Company’s operating results.EBDDT for 2008 includes areduction for deferred income taxes of $780,125 or $.14 per share associatedwith increased pension liabilities charged to shareholder equity.William H. The exact amount is not determined at this point.There is not word on how big a deal Hardy got, but I assume it was good enough if he signed. Vrabel went from a career-high 12.5 sacks in 2007 to just four last season. (“ISI”) has made a proposed offer to purchase all the outstandinglegacy assets and intellectual property of its business partner, ItibitiInc.
He survived that inning, but wasn’t so fortunate in the ninth.He certainly wasn’t helped by shortstop Ryan Theriot, who made a poor decision to make an off-balanced throw home on a ball that appeared to be tailor made for a double play. Martinez said industry projections were optimistic andexpects automobile production to fall around 35 percent thisyear, further dragging down the entire economy (Editing by Leslie Adler) Mexico. The Mets might also want to add 40 to 1969 and see what number they get 2 Banner Day. An actual unique Mets tradition Bring it back. That’s providing greatervalue for business owners at a time when they need it the most.” With this new product, small businesses earn rewards miles automatically foreveryday business transactions, including writing a check, making a debit cardpurchase or paying a bill online. 5.) Ryan Doumit – Clearly outside the top tier, but has all the tools to join the elite by year’s end. Has decent pop, and hits for a high average, while a weak lineup will stymie his RBI potential. Should bat cleanup and provide protection for Nate McClouth. Unfortunately for Maynard, while another win is great, he’s not making a lot of fans with his lack of finishes. He then starts to make his way down to the ring to confront Orton Orton begins to try to coax Hunter into losing the hammer.
“I have been a head coach for 12 years, but I’m an offensive line coach by trade. Beyond the product launch,the company adds value by managing service support, organizing reliabilitystudies, and driving cost reductions for customers to gain a competitiveadvantage. Kent cautions investors not to place undue reliance onforward-looking statements, which speak only to management’s expectationson this date. That is a phenomenal season, the best of his career. 2007His stats went slightly down when he scored 15 times, still leading the league though. Therefore I think the lines are just fine, like I said before team win on the road by greatgoaltender not by offense.
If you're lucky, you can get three lefties in your everyday lineup Worst case, you can get a big lefty bat for the bench. Pentagonthat would trim missile-defense spending and cancel some bigweapons programs Stocks The recommendations announced by U.S. This report analyzes the worldwide markets for First Aid Kits in Millions ofUS$. With Sheraton being the only five-star hotel at the time, the Raiders would always rent a whole floor for their team.My uncle loved the passion that emanated form those group of guys and loved Raider football.
According to reports, coach Dan Campbell said, “When these kids try to make weight, sometimes they cut corners. NEW DELHI, April 16 (Reuters) – India’s Company Law Board(CLB) on Thursday approved the takeover of fraud-hit SatyamComputer Services Ltd (SATY.BO) by mid-sized outsourcer TechMahindra Ltd (TEML.BO), as had been expected. They have plenty of veteran leadership and guys that have been there before and know what it takes to win big games. Consumers create exciting, personalized brand-focuseduser-generated content (UGC) and then virally share the campaign and theircontent with their vast social networks via widgets, blogs, IM, email and more.Campaign participants interact with the brand campaign in a variety of ways thatinclude creating, reviewing, sharing, voting upon, and watching brand-relevantcontent. That’s a good way to wind up losing one of the Big Two’s starts, games that the Cards are going to have to win to have a chance for the trophy.So the Cardinals have to find a way to score some runs earlier in the ballgame behind the two aces.
MADRID (AFP) – El Barcelona consolidó su liderato en la liga española tras ganar al Getafe (2-1), este sábado en partido adelantado de la 21ª jornada, gracias a un gol de Leo Messi y a una asistencia del argentino a Xavi Hernández, en un duelo que el equipo catalán terminó con nueve hombres.
Shares in PKN rose 2.2 percent late in the session, in linewith the wider market. The stock has gained 9.4 percent so farthis year, outperforming a 7.7 percent rise of Warsaw’s mainWIG20 index .WIG20 (Editing by David Jones). BEIJING, June 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd.(NYSE Amex: SVA), a leading developer and provider of vaccines in China,announced today that the Company received the first order in China to supplyits influenza A (H1N1) vaccine to the Beijing government. The initial orderconsists of 4 million doses and is expected to be delivered by the end ofSeptember.This order will be administered to 2 million people in the highrisk group.Additional orders are expected beginning in October and, intotal,Sinovac expects to supply approximately 10 million doses to the Beijinggovernment.The 10 million doses will be administered to 5 million people inBeijing.On June 14, 2009, Sinovac completed construction of the H1N1 virus seedbank necessary to produce a virus antigen and commenced production of thefirst batch of H1N1 vaccine.Sinovac expects to complete production of thefirst batch by the end of July.Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, “Weare organizing and coordinating all personnel and resources to produce theH1N1 vaccine, as we have almost completed the production of our seasonalinfluenza vaccine.With the support and instruction of the relevantgovernment and health authorities, Sinovac will fully utilize its provendevelopment and production abilities from both the H5N1 vaccine and seasonalflu vaccine to ensure the efficient production of the H1N1 vaccine.We areworking closely with authorities in order to contribute to the prevention andcontrol of the H1N1 epidemic situation.”About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases.
Sinovac’s vaccineproducts include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A andB), and Anflu(R) (influenza). Panflu(TM), Sinovac’s pandemic influenza vaccine(H5N1), has already been approved for government stockpiling.Sinovac isdeveloping vaccines for enterovirus 71, universal pandemic influenza, Japaneseencephalitis vaccine, and human rabies vaccine.Its wholly owned subsidiary,Tangshan Yian, is conducting field trials for independently developedinactivated animal rabies vaccines.Safe Harbor StatementThis announcement contains forward-looking statements. These statementsare made under the “safe harbor” provisions of the U.S Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as “will,” “expects,” “anticipates,”"future,” “intends,” “plans,” “believes,” “estimates” and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements.
Statements that are nothistorical facts, including statements about Sinovac’s beliefs andexpectations, are forward-looking statements. Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement. Sinovac does not undertake any obligation to updateany forward-looking statement, except as required under applicable law.For more information, please contact: Helen G Yang Sinovac Biotech Ltd.
Tel: +86-10-8289-0088 x9871 Fax: +86-10-6296-6910 Email: Investors: Amy Glynn/Sara Pellegrino The Ruth Group Tel: +1-646-536-7023/7002 Email: Media: Janine McCargo The Ruth Group Tel: +1-656-536-7033 Email: SOURCESinovac Biotech Ltd.Helen G. Yang of Sinovac Biotech Ltd., +86-10-8289-0088 x9871, fax:+86-10-6296-6910 or ; or Investors: Amy Glynn & SaraPellegrino of The Ruth Group at +1-646-536-7023 & 7002 & ; Or Media: JanineMcCargo of The Ruth Group, +1-656-536-7033 or . TAMPA, FL, Jun 19 (MARKET WIRE) — Tampa-based HomeBancorp, Inc has named Jack Summers as Mortgage LoanOfficer for HomeBanc. He is based in the bank’s Lake Mary loan productionoffice, located at 100 Colonial Center Parkway, Suite 100.Mr. Summers brings to HomeBanc more than 35 years of mortgage bankingexperience. He can be reached at (321) 832-1368 eBanc is a wholly owned subsidiary of Tampa-based HomeBancorp, Inc.,with full-service branch locations in Lake Mary, Lakewood Ranch(Sarasota), Belleair Bluffs and three branches in Tampa at Rocky Point,on Dale Mabry at I-275 and Westchase. HomeBanc also operatesloan-production offices in Tampa, Lake Mary and Brandon.HomeBanc offers an array of retail-deposit products, along with SBA loans,special lower-rate FHA loans for first-time buyers, residential mortgageloans and non-traditional jumbo mortgage loans.
YAKARTA (AFP) – ¿Permitirá el Año del Tigre, que comienza el domingo, salvar al más grande de los felinos? Esto esperan los ambientalistas y defensores de los animales, que han lanzado una campaña de movilización masiva en Asia, donde viven los últimos tigres en libertad.
The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation.
Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did. The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights.
Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine. “Shareholders will find a solution which won’t createproblems for the bank,” Passera said on the sidelines of aconference in Milan He gave no further details. One analyst suggested Intesa Sanpaolo might try to share thepossible fine with Credit Agricole and Generali. Passera also confirmed the bank would soon take advantage ofgovernment-backed bonds aimed at boosting Italian banks’capital.
Intesa shares were down 3.1 percent at 2.265 euros by 1422GMT while Credit Agricole was broadly flat The DJ Stoxx indexof banks .SX7P was up 0.91 percent (writing by Jo Winterbottom, Editing by Andy Bruce) Italy. CINCINNATI–(Business Wire)–Starbucks Corporation (NASDAQ: SBUX) attracted a slew of put traders onThursday, after the java giant recalled more than half a million coffeegrinders. According to data from WhatsTrading , the equity saw nearly 8,750puts cross the tape yesterday, more than doubling its average single-sessionvolume of roughly 4,000 contracts. Most active was the July 14 put, which saw about 5,700 contracts change handsyesterday. The at-the-money option – which assumes front-month status after theclosing bell today – saw open interest climb from 5,948 to 10,932 overnight,suggesting most of the activity was of the buy-to-open variety. What’s more, theSBUX July 14 put remains popular today, with nearly 1,800 contracts exchangedwithin the first hour of trading. To continue reading this article, click here: http://’s Investment ResearchAndrea Kramer, Copyright Business Wire 2009.
PEKÍN (AFP) – - Las tenistas españolas María José Martínez y Anabel Medina se impusieron este domingo en sus partidos de la primera ronda del torneo de tenis WTA de Pekín, al derrotar, respectivamente, a la danesa Caroline Wozniacki, quinta favorita del certamen, y a la china Lu Jingjing.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.
KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.
The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units.
